about
EspP, an Extracellular Serine Protease from Enterohemorrhagic E. coli, Reduces Coagulation Factor Activities, Reduces Clot Strength, and Promotes Clot LysisMultiple Testing in the Context of Gene Discovery in Sickle Cell Disease Using Genome-Wide Association Studies.Optimal Manual Exchange Transfusion Protocol for Sickle Cell Disease: A Retrospective Comparison of Two Comprehensive Care Centers in the United Kingdom and Canada.A retrospective observational study of leucoreductive strategies to manage patients with acute myeloid leukaemia presenting with hyperleucocytosis.A proposed treatment algorithm for adults with Haemoglobin SC disease.Safety and pharmacokinetics of the oral iron chelator SP-420 in β-thalassemia.Safety and feasibility of red cell exchange for sickle cell disease across Canada.A comparison of chronic manual and automated red blood cell exchange transfusion in sickle cell disease patients.The clinical spectrum of pyruvate kinase deficiency: data from the Pyruvate Kinase Deficiency Natural History Study.Cord gas parameters in infants born to women with sickle cell disease: a retrospective matched cohort study.Extracorporeal photopheresis in solid organ transplant-associated acute graft-versus-host disease.Prospective Evaluation of an R2* Method for Assessing Liver Iron Concentration (LIC) Against FerriScan: Derivation of the Calibration Curve and Characterization of the Nature and Source of Uncertainty in the RelationshipManagement of Polycythemia Vera: A Survey of Canadian Physician Practice PatternsGenotype-phenotype correlation and molecular heterogeneity in pyruvate kinase deficiencyImpact of a transition program with navigator on loss to follow-up, medication adherence, and appointment attendance in hemoglobinopathiesDeferiprone exerts a dose-dependent reduction of liver iron in adults with iron overloadThe pyruvate kinase (PK) to hexokinase enzyme activity ratio and erythrocyte PK protein level in the diagnosis and phenotype of PK deficiency
P50
Q33430429-2803605B-302A-4335-A2E3-A8352FFE64D9Q41232448-C9B8C758-10D9-42B0-89EB-C9D743EA8F09Q41638881-C3A00E46-9611-440A-AEC9-D60D3B86DFCDQ47571447-3B14EA6E-53C7-4342-831E-4923D41F2C79Q47769660-1A781F6F-09B0-4486-B111-8189EB19AC7CQ48306161-874A14B4-1DAF-4D74-89E6-978046D18247Q50240186-924C03D9-030C-460C-84C5-7526529BC479Q50452880-575394D8-CA26-4E6F-9A2A-ED6BE8DA3244Q52651299-61FED3C7-55CF-43E7-96D8-619C772EA35BQ52731077-FF0186C3-057E-4A61-8F1C-69225D94C309Q53173019-CCC97529-7769-4B02-9FD1-9AE7326FDD6AQ57020639-9CE98E9D-6570-4E6E-99FD-9EEE9E5191B1Q57495018-DF76A4B8-B336-406B-BB5E-0904BC679FAFQ89645740-B8171A23-0EB7-45B4-9E88-4D4D9733EBDAQ91689262-30728F2E-581C-4159-AABB-1E382649B37FQ91850466-AC4C3061-6980-40D6-9877-5C169F497BCFQ95940728-8C5748CA-7492-4029-80FA-3CFEE8CEA1F6
P50
description
investigador
@es
researcher
@en
name
Kevin H M Kuo
@en
type
label
Kevin H M Kuo
@en
prefLabel
Kevin H M Kuo
@en
P31
P496
0000-0002-6744-9238